Somerville Kurt F Danaher Corp Transaction History

Somerville Kurt F

$606 Million
Q3 2024

A detailed history of Somerville Kurt F transactions in Danaher Corp stock. As of the latest transaction made, Somerville Kurt F holds 77,517 shares of DHR stock, worth $18.1 Million. This represents 3.56% of its overall portfolio holdings.

Number of Shares

77,517

Previous 77,964 0.57%

Holding current value

$18.1 Million

Previous $19.5 Million 10.62%

% of portfolio

3.56%

Previous 3.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$239.25 - $280.76 $106,944 - $125,499	-447 Reduced 0.57%	77,517 $21.5 Million
Q2 2024 Aug 12, 2024	BUY	$235.51 - $267.98 $54,638 - $62,171	232 Added 0.3%	77,964 $19.5 Million
Q1 2024 May 13, 2024	BUY	$224.58 - $256.19 $633,091 - $722,199	2,819 Added 3.76%	77,732 $19.4 Million
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $468,488 - $590,052	2,531 Added 3.5%	74,913 $17.3 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $248,929 - $283,650	1,068 Added 1.5%	72,382 $18 Million
Q2 2023 Aug 11, 2023	SELL	$224.99 - $256.14 $1.92 Million - $2.18 Million	-8,527 Reduced 10.68%	71,314 $17.1 Million
Q1 2023 May 10, 2023	SELL	$239.75 - $277.0 $69,767 - $80,607	-291 Reduced 0.36%	79,841 $20.1 Million
Q4 2022 Feb 09, 2023	SELL	$241.42 - $282.29 $64,217 - $75,089	-266 Reduced 0.33%	80,132 $21.3 Million
Q3 2022 Nov 08, 2022	SELL	$247.06 - $1507.4 $151,200 - $922,528	-612 Reduced 0.76%	80,398 $20.8 Million
Q2 2022 Jul 19, 2022	SELL	$237.11 - $299.66 $50,741 - $64,127	-214 Reduced 0.26%	81,010 $20.5 Million
Q1 2022 May 17, 2022	SELL	$257.27 - $315.76 $1.78 Million - $2.19 Million	-6,930 Reduced 7.86%	81,224 $23.8 Million
Q4 2021 Feb 08, 2022	SELL	$292.08 - $329.01 $1.29 Million - $1.45 Million	-4,422 Reduced 4.78%	88,154 $29 Million
Q3 2021 Nov 10, 2021	SELL	$272.21 - $332.43 $1.5 Million - $1.83 Million	-5,501 Reduced 5.61%	92,576 $28.2 Million
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $228,456 - $275,765	-1,015 Reduced 1.02%	98,077 $26.3 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $85,801 - $99,343	-404 Reduced 0.41%	99,092 $22.3 Million
Q4 2020 Feb 16, 2021	SELL	$212.5 - $245.46 $1.57 Million - $1.81 Million	-7,393 Reduced 6.92%	99,496 $22.1 Million
Q3 2020 Oct 28, 2020	SELL	$177.16 - $215.33 $689,861 - $838,495	-3,894 Reduced 3.51%	106,889 $23 Million
Q2 2020 Jul 28, 2020	SELL	$128.7 - $176.83 $196,267 - $269,665	-1,525 Reduced 1.36%	110,783 $19.6 Million
Q1 2020 May 07, 2020	SELL	$121.39 - $169.05 $205,027 - $285,525	-1,689 Reduced 1.48%	112,308 $15.5 Million
Q4 2019 Jan 15, 2020	SELL	$133.47 - $153.48 $335,810 - $386,155	-2,516 Reduced 2.16%	113,997 $17.5 Million
Q3 2019 Nov 06, 2019	SELL	$135.4 - $146.47 $336,198 - $363,685	-2,483 Reduced 2.09%	116,513 $16.8 Million
Q2 2019 Jul 24, 2019	SELL	$124.88 - $143.73 $775,504 - $892,563	-6,210 Reduced 4.96%	118,996 $17 Million
Q1 2019 May 01, 2019	BUY	$97.62 - $132.29 $119,877 - $162,452	1,228 Added 0.99%	125,206 $16.5 Million
Q4 2018 Jan 24, 2019	BUY	$94.85 - $109.54 $74,457 - $85,988	785 Added 0.64%	123,978 $12.8 Million
Q3 2018 Oct 15, 2018	BUY	$98.13 - $108.9 $106,961 - $118,701	1,090 Added 0.89%	123,193 $13.4 Million
Q2 2018 Jul 30, 2018	BUY	$96.1 - $103.24 $81,204 - $87,237	845 Added 0.7%	122,103 $12 Million
Q1 2018 Apr 24, 2018	SELL	$92.16 - $103.8 $452,782 - $509,969	-4,913 Reduced 3.89%	121,258 $11.9 Million
Q4 2017 Feb 02, 2018	SELL	$85.26 - $94.62 $360,649 - $400,242	-4,230 Reduced 3.24%	126,171 $11.7 Million
Q3 2017 Oct 26, 2017	BUY	$79.29 - $88.45 $10.3 Million - $11.5 Million	130,401	130,401 $11.2 Million

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Danaher Corp Transaction History